Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The opioid crisis and HIV in the USA: deadly synergies
Sally Hodder, Judith Feinberg, Steffanie A. Strathdee, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1139-1150
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19
Sarah Brothers, Adam Viera, Robert Heimer
Journal of Substance Abuse Treatment (2021) Vol. 131, pp. 108449-108449
Open Access | Times Cited: 89
Advances in the treatment of neuropathic pain
Nadine Attal, Didier Bouhassira
Current Opinion in Neurology (2021) Vol. 34, Iss. 5, pp. 631-637
Closed Access | Times Cited: 56
Call to action: how can the US Ending the HIV Epidemic initiative succeed?
Chris Beyrer, Adaora A. Adimora, Sally Hodder, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1151-1156
Open Access | Times Cited: 41
Global HIV control: is the glass half empty or half full?
Jean B. Nachega, Philippa Musoke, Peter H. Kilmarx, et al.
The Lancet HIV (2023) Vol. 10, Iss. 9, pp. e617-e622
Open Access | Times Cited: 21
μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial
Xiaoqiang Wang, Song Zhang, Di Jin, et al.
Cancer Communications (2023) Vol. 43, Iss. 3, pp. 365-386
Open Access | Times Cited: 16
Characterizing Opioid Withdrawal Experiences and Consequences Among a Community Sample of People Who Use Opioids
Kelsey A. Simpson, Maria Bolshakova, Matthew G. Kirkpatrick, et al.
Substance Use & Misuse (2024) Vol. 59, Iss. 6, pp. 886-894
Open Access | Times Cited: 7
The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine
Roman Ivasiy, Lynn M. Madden, Anna Meteliuk, et al.
Addiction (2024) Vol. 119, Iss. 9, pp. 1585-1596
Closed Access | Times Cited: 7
Ending the HIV epidemic in US Latinx sexual and gender minorities
Carlos E. Rodríguez-Díaz, Omar Martínez, Sean Bland, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1043-1045
Open Access | Times Cited: 36
Diagnosis and Management of Neuropathic Pain in Spine Diseases
Joanna Bielewicz, Maciej Kamieniak, Michał Szymoniuk, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1380-1380
Open Access | Times Cited: 14
PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high
Mary A. Hatch, Tanja C. Laschober, Margaret M. Paschen-Wolff, et al.
Drug and Alcohol Dependence (2024) Vol. 257, pp. 111133-111133
Closed Access | Times Cited: 5
Xenon gas as a potential treatment for opioid use disorder, alcohol use disorder, and related disorders
Marc J. Kaufman, Edward G. Meloni
Medical Gas Research (2025)
Closed Access
Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opiod use disorder in the United States
Roman Ivasiy, Lynn M. Madden, Kimberly Johnson, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104748-104748
Closed Access
Same script, different viruses: HIV and COVID-19 in US Black communities
Errol L. Fields, Raniyah Copeland, Ernest Hopkins
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1040-1042
Closed Access | Times Cited: 31
Addressing long overdue social and structural determinants of the opioid epidemic
Nabila El‐Bassel, Steven Shoptaw, David Goodman‐Meza, et al.
Drug and Alcohol Dependence (2021) Vol. 222, pp. 108679-108679
Closed Access | Times Cited: 31
Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
Kathleen Ward, Ayden I. Scheim, Jonathan Wang, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 3, pp. 100055-100055
Open Access | Times Cited: 22
Structure–Activity Relationship Analysis of Meta-Substituted N-Cyclopropylmethyl-Nornepenthones with Mixed KOR/MOR Activities
Siyuan Tang, S. Hu, Feng Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117449-117449
Closed Access
The synthetic opioid fentanyl increases HIV replication in macrophages
Janani Madhuravasal Krishnan, Ling Kong, Heidi L. Meeds, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0298341-e0298341
Open Access
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods
James L. Merle, Juan Pablo Zapata, Artur Quieroz, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years
Roman Ivasiy, Lynn M. Madden, Scott O. Farnum, et al.
Drug and Alcohol Dependence Reports (2022) Vol. 4, pp. 100075-100075
Open Access | Times Cited: 13
Past-year medical and non-medical opioid use by HIV status in a nationally representative US sample: Implications for HIV and substance use service integration
Brooke S. West, José E. Diaz, Morgan M. Philbin, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 147, pp. 208976-208976
Open Access | Times Cited: 7
Attitudes of Black American Christian church leaders toward Opioid Use Disorder, overdoses, and harm reduction: a qualitative study
Akosua B. Dankwah, Richard B. Siegrist, Ira B. Wilson, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection
Howard S. Fox, Meng Niu, Brenda Morsey, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Association of Illicit Fentanyl Use with Injection Risk Practices Among People who Inject Drugs
Kathleen S. Kenny, Gillian Kolla, Sarah Greig, et al.
AIDS and Behavior (2022) Vol. 27, Iss. 6, pp. 1757-1765
Closed Access | Times Cited: 11
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder
William H. Eger, Frederick L. Altice, Jessica Lee, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
Amy Corneli, Brian Perry, Andrea C. Des Marais, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top